Azizi Developments Announces Sales Launch for Burj Azizi, the World’s Second-Tallest Tower at 725m
Azizi Developments, a leading private developer in the UAE, will officially launch the sales of Burj Azizi, the world’s second-tallest tower, standing at an impressive 725 meters tall on a prime plot of land on Dubai’s Sheikh Zayed Road.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250218423172/en/
“Burj Azizi” (Photo: AETOSWire)
The grand launch event will be held at the Coca Cola Arena, City Walk on February 18th, featuring a headline performance by American singer Jennifer Lopez (JLo) and will welcome over 15,000 attendees. Among the guests are government officials, media representatives, brokerage partners, banks and financial institutions, investors, high-profile influencers and various celebrities.
Scheduled for completion by 2028, the 131+ story tower offers suites, penthouses, apartments, and holiday homes priced between AED 10,000 and AED 17,000 per square foot. It will also include an all-suite seven-star hotel inspired by seven cultural themes.
Burj Azizi’s extensive amenities incorporate wellness centers, swimming pools, saunas, cinemas, gyms, mini markets, resident lounges, and a children’s play area. As the only freehold property on Sheikh Zayed Road, the tower will also house a vertical retail center spread across seven floors, a luxury ballroom, a beach club, a distinctive observation deck, an adrenaline zone, and a variety of high-end dining options.
Once completed, Burj Azizi is poised to set numerous new world records, including the highest hotel lobby on level 11, the highest nightclub on level 126, the highest observation deck on level 130, the highest restaurant in Dubai on level 122, and the highest hotel room in Dubai on level 118.
Additional sales launch events will be held on the 19th of February at prestigious venues across the world, including the Conrad Hotel in Dubai, The Peninsula in Hong Kong, The Dorchester in London, JW Marriott Juhu in Mumbai, New York Marriott Downtown, Marina Bay Sands in Singapore, Four Seasons Hotel in Sydney, and the Palace Hotel in Tokyo.
Mr. Farhad Azizi, Group CEO of the Azizi group of companies, said: “Our Burj Azizi sales launch event will mark one of our proudest moments to date. It is one of the most significant milestones in our mission to redefine luxury living and architectural innovation while shaping Dubai’s iconic skyline. Burj Azizi will stand as a testament of the UAE’s ambition and pursuit of excellence, offering unparalleled ultra-luxury residences, world-class amenities, and record-breaking features that set new benchmarks in the industry, globally.”
He added: “I extend my deepest gratitude to His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, for his visionary leadership, and to the Dubai authorities for their invaluable support in making this groundbreaking project possible. Burj Azizi is not just a structure; it is a tribute to the emirate’s ever-growing prominence on the global stage. We are honored to play a role in forming this city’s legacy, one that will prevail for all generations to come.”
About Azizi Developments
Azizi Developments is a leading developer based in Dubai, UAE. With more than 30,000 homes successfully delivered to local and international investors and end users of over 100 nationalities, the developer prides itself on its extensive portfolio of modern luxury developments across Dubai’s most sought-after residential and commercial destinations, its construction-driven approach, and its commitment to transparency and customer centricity. Azizi’s residential and commercial properties are investor friendly, catering to all lifestyles. The developer makes it its international mission to develop lifestyles and enrich the lives of its residents with a focus on catalyzing the vision and development of the markets that it operates in.
Azizi currently has around 40,000 units under construction that are projected to be delivered by 2027, worth several billion US dollars. The company is renowned for developing the world’s second tallest skyscraper and an AED 2.5 billion opera, which is its gift to the city, as part of its cultural district at Azizi Venice. Azizi has a strong track record and sizeable project pipeline through its extensive land bank and strategic partnerships with Dubai’s key master developers, and is instrumental in developing world-class properties in MBR City, Palm Jumeirah, Sheikh Zayed Road, Dubai Healthcare City, Dubai South, Al Furjan, Studio City, Sports City and Downtown Jebel Ali.
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20250218423172/en/
Contacts
Azizi Developments
Tizian H. G. Raab
Head of Public Relations and Communications, CEO’s Office
M: +971558673606
Email: tizian@azizidevelopments.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 02:00:00 CET | Press Release
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn
Enry's Island SpA Strengthens Its Leadership in Venture Capital with Explosive Growth and Redesigns the Future of VC Through Gaming19.12.2025 00:34:00 CET | Press Release
Enry’s Island SpA (WBAG:EIOS), the world’s first publicly listed venture builder, announces a new era of growth, innovation, and the democratization of Venture Capital (VC). The company has delivered exceptional results, consolidating its position as an industry leader through a strategic positioning in the rapidly expanding gaming market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218742236/en/ Record Growth and Performance Enry’s Island SpA has demonstrated an extraordinary growth trajectory and a strong financial and operational track record: Revenues: +250% year-over-year (YoY). Exit: $3.6M in exits realized via IPO. Portfolio: 1 IPO of a portfolio company completed in December 2024, with an additional 2 IPOs expected in 2026. The performance of the EIOS:VSE stock reflects this strength: Price per Share (PPS): +132% in the first half (H1) of 2025, stabilizing at a +116% YTD increase. Daily Trading Volume: peaks of
500 Global Expands Africa Presence; Selected to Advance Digital Morocco 2030 Strategy18.12.2025 21:37:00 CET | Press Release
500 Global, one of the world’s most active venture capital firms1, announced it has been selected to support the Ministry-led Startup VB initiative, a flagship program under the Digital Morocco 2030 strategy2. This announcement marks a significant milestone in 500 Global’s continued expansion across the African continent and its work collaborating with governments to strengthen national innovation ecosystems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218363323/en/ Announcement of 500 Global's continued expansion across Africa and support of Digital Morocco 2030 Launched by the Ministry of Digital Transition and Administrative Reform (Ministry) and deployed by TAMWILCOM, the Startup VB initiative is a flagship program under the Digital Morocco 2030 strategy. Startup VB aims to strengthen Morocco’s innovation and digital competitiveness by accelerating high-potential founders and providing the training and financing pa
Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering18.12.2025 17:00:00 CET | Press Release
Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with existing investors Forestay Capital, Alven, HTGF, D.E. Shaw Ventures and Aster Capital. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218764112/en/ Image courtesy of Neural Concept (L-R clockwise from top) Jonathan Donier, CSO & Co-founder; Thomas von Tschammer, Managing Director US & Co-founder; Théophile Allard, CTO & Co-founder; Pierre Baqué CEO & Co-founder; Philippe Cuendet, COO Neural Concept is redefining engineering workflows with CAD-native enterprise AI that understands geometry, constraints and design intent. By helping its customers build and deploy physics-aware design copilots, the platform enables teams to explore millions of design options earlier and avoid costly la
Croma-Pharma Introduces New Medical Device for the Preparation of Autologous PRP | Fluid- PRF18.12.2025 16:57:00 CET | Press Release
Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of autologous blood concentrates, without the use of anticoagulants, resulting in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes, yet stays liquid for a defined period.1 What makes Exprecell™ special? MDR certification: Exprecell™ is MDR-certified, meeting stringent EU regulatory requirements to ensure the safe, controlled and standardized preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom